Drugs / MD-18
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06739707 | Jan 2025 → Dec 2026 | — | Cohen Global, Ltd. | Suspended | No outcome recorded Stop: Business |
| Phase 1 | NCT06259903 | May → Dec 2024 | — | Cohen Global, Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MD-18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06259903 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT06259903 ↗ |